Literature DB >> 1630299

Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman.

M K Bodén1, J I Flock.   

Abstract

Binding of extracellular components of Staphylococcus aureus strain Newman to fibrinogen and prothrombin was investigated. Affinity-purified material from fibrinogen- and prothrombin-Sepharose was analysed on immunoblots, and two proteins with coagulase activity were identified. The two coagulases were produced in a sequential manner during staphylococcal growth. An 87 kDa fibrinogen-binding coagulase was produced mainly during the exponential growth phase and was replaced by a 60 kDa fibrinogen- and prothrombin-binding coagulase which was produced mainly during the post-exponential growth phase. In addition, a 19 kDa fibrinogen-binding protein was constitutively produced. Analyses of immunogenic properties and NH2-terminal sequences suggested that the 19, 60 and 87 kDa fibrinogen-binding proteins are not closely related. The NH2-terminal sequence of the 87 kDa protein is identical to a previously described coagulase from Staphylococcus aureus strain 8325-4. The 19 kDa fibrinogen-binding protein, which spontaneously aggregates into dimers and larger molecular weight complexes, had a unique NH2-terminal sequence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1630299     DOI: 10.1016/0882-4010(92)90047-r

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  30 in total

1.  Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus.

Authors:  J M Entenza; T J Foster; D Ni Eidhin; P Vaudaux; P Francioli; P Moreillon
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

4.  The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution.

Authors:  Michal Hammel; Daniel Nemecek; J Andrew Keightley; George J Thomas; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

5.  Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis.

Authors:  L Pei; M Palma; M Nilsson; B Guss; J I Flock
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Influence of agr on fibrinogen binding in Staphylococcus aureus Newman.

Authors:  C Wolz; D McDevitt; T J Foster; A L Cheung
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism.

Authors:  P Saravia-Otten; H P Müller; S Arvidson
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

Review 8.  Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Authors:  Brandon L Garcia; Kasra X Ramyar; Daniel Ricklin; John D Lambris; Brian V Geisbrecht
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

9.  A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family.

Authors:  H s Tung; B Guss; U Hellman; L Persson; K Rubin; C Rydén
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

10.  The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.

Authors:  Jordan L Woehl; Kasra X Ramyar; Benjamin B Katz; John K Walker; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2017-05-31       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.